:format(webp))
Let’s move precision oncology forward – together.
We partner with ambitious teams to develop cancer therapeutics where patient, target, and modality align.
Whether you’re looking to access de-risked assets to move to the clinic faster and more confident, or building new programs from the ground up, we’re your R&D partner for successful therapeutics design.
High-value opportunitiesPatient data. De-risked targets. Co-owned programs.
We bring together scientific expertise and data depth to decipher the complexity of cancer. Every decision, from target selection and patient stratification to modality fit, is grounded in patient-native biology and deep clinical insights.
With a patient-first mindset and a focus on collaboration, we can drive innovative R&D programs faster, smarter, and with greater confidence toward the clinic and beyond.
)
Built for translationAccess de-risked target packages
Grounded in patient insights, our pipeline delivers validated targets with built-in patient stratification and modality fit, tailored screening assays, and optimized hit molecules, designed to de-risk where it matters most: before the clinic.
Flexible partnering models give you assets built for speed, regulatory confidence, and clinical success.
)
Grounded in patient-driven insightsCocreate novel pipelines.
Together, we build new drug programs from the very beginning, starting with disease biology, patient data, and novel targets.
Our proprietary patient cohorts in solid tumors gives us a patient-native foundation. Depending on your focus, we can also build new cohorts through our Global Clinical Network.
From discovery through to the clinic, we move forward with you at every step.
:format(webp))
“We know which targets matter, and for which patients. Translating that into the right modalities and partnering to develop therapies that reach the clinic faster is what drives us.”